Login
Biotech company goes public
A NewLaw firm has advised a drug discovery and development company on its ASX listing and initial public offering.
Emma Musgrave
Firm: Hive Legal (AdAlta Limited)
Value: $10 million
Area: IPO
Key players: The Hive Legal team was led by principal and founder Simon Davidson, with assistance from associate Rohila Rahimi and lawyer Mathika Perera.
Deal significance: AdAlta Limited is a drug discovery and development company focused on using its novel technology platform to generate i-bodies.
The unique platform has been applied to the first drug development candidate to treat fibrosis. The company will use its IPO funds to complete the first phase of a clinical study to validate its lead candidate drug, which was developed based on AdAlta’s platform.
“Working with Simon [Davidson], right from the start, meant that we had a clear line of sight on the legal process and the resources and costs needed to achieve the listing,” said Sam Cobb, CEO of AdAlta.
“That clarity is particularly important for biotech companies like ours as we work through the steps on our drug development journey.”
Emma Musgrave
Emma Musgrave (née Ryan) is the managing editor, professional services at Momentum Media.
Emma has worked for Momentum Media since 2015, including five years spent as the editor of the company's legal brand - Lawyers Weekly. Throughout her time at Momentum, she has been responsible for breaking some of the biggest stories in corporate Australia. In addition, she has produced exclusive multimedia and event content related to the company's respective brands and audiences.
Prior to joining Momentum Media, Emma worked in breakfast radio, delivering news to the Central West region of NSW, before taking on a radio journalist role at Southern Cross Austereo, based in Townsville, North Queensland.
She holds a Bachelor of Communications (Journalism) degree from Charles Sturt University.
Email Emma on:
